Modern new biotechnology has the potential to provide major economic and other benefits, but at the same time it poses potential hazards for human health, the environment, the 'natural' biological order and can have adverse socio-economic consequences. The application of such technology frequently violates traditional ethical, moral and religious values. This paper after outlining possible benefits of modern new biotechnologies, discusses the type of biosafety risks which they pose, their possible adverse consequences for the sustainability of biodiversity and agriculture and their potential impacts on socioeconomic welfare and traditional cultures. Particular concern is expressed about the possible consequences of such technologies for developing countries and the practice in some developed countries of issuing patents conferring very broad rights over the use of genetically engineered material. Because these rights are so broad in some cases they have the potential to establish powerful multinational monopolies in the hands of private companies. Global debate about these issues suggest that more emphasis should be given globally to the socio-economic consequences of such technology than in the past. The need for this is highlighted by the North-South divide. Developing countries lag considerably in this new technological field, are placed in a dependant position and have weak institutional structures to control the application of such technology.
Introduction:
Biotechnology is a modern advanced technology based scientific fields such as on molecular biology, biochemistry, cell biology. It adopts many new techniques such as cell and tissue cultivation, cell fusion, gene recombination, microbal fermentation, so as to duplicate and recombine the organisms at the level of cell, chromosome, and gene, and create the best state of organisms according to human desires, and to produce new products and breed new fine varieties with novel traits of high productivity and stress resistance. Modern biotechnology is composed of four technological systems. They are genetic engineering, cell engineering, enzyme engineering and fermentation engineering, of which genetic engineering and cell engineering are the most recent advanced biotechnologies.
Modern biotechnology can not only produce great social and economic benefits, but can also do harm to human health, environment, and result in many socioeconomic problems, such as destroying original social and economic pattern, posing threats to biodiversity and traditional crop varieties, injuring country's or a community's socioeconomic welfare, violating traditional ethical, moral and religious value. In order to enable biotechnology contribute major benefits to human beings at and to so safety, international society has paid great attention to the biosafety of living modified organisms (LMOs) produced by biotechnology.
Social and economic benefits of modern biotechnology
Biotechnologies are being used widely in such fields as medicine and hygiene, agriculture, forestry, raising, fisheries, energy and chemical industries, metallurgical and mining industries, food and light industries, environmental protection. Modern biotechnology has gradually demonstrated its huge potential contribution to productivity, though it has a short history of only tens of years so far. Modern biotechnology will become powerful means to reduce the world's constraints in the fields of food, health, energy, resources and environment. The development and application of modern biotechnology will, over a long period of time, affect human beings and society deeply. Biotechnological industries are likely to become the leading industries in the 21st century. For example, crop varieties, produced by biotechnology, with novel traits of high productivity and stress resistance (aridity, coldness, high salt, etc) are expected not only to increase grain productivity, but also decrease the use of agricultural chemicals (such as pesticide, herbicide and fertilizer), which will be beneficial to environment. In the respect of medicine and hygiene, many drugs such as DNA vaccines, protein engineering medicine, monoclonal antibodies, antisense RNA drugs have been developed by biotechnology. Transgenic animals and plants producing some kinds of medicines (such as vaccines and hormone) may help to reduce illness in the process of everyday diet. Human Genome Project (HGP) and the research into some disease genes will discover the genetic reasons for some illnesses. Environmental pollution is getting worse at present, but biological transformation reactors created by biotechnology promise to absorb pollutants or wastes and decompose them into materials of low or no toxicity. 
Biosafety issues of modern biotechnology
Inappropriate application of biotechnology can result in many risks/hazards, just as other advanced technologies such as nuclear technology. Has done. For examples, the new genes in crop produced by genetic engineering can result in allergic reactions.
Organism fed with genetically manipulated food for a long period of time may develop fatal diseases such as cancers. Being given the traits of pest-resistance, herbicide-resistance or stress-resistance, transgenic plants may escape from agricultural cultivation systems to evolve into vicious weeds. The resistance genes in transgenic plants may also be transferred to their wild weedy relatives, and the latter's fitness might be improved to become "super" weeds which will make them more difficult to control. Large-scale environmental releases of transgenic pest-resistance crops will create huge selection pressures to accelerate the resistance of target pests. 
Potential adverse impacts of modern biotechnology on socioeconomics
Modern biotechnology may also have many unfavorable impacts on society and economic conditions as discussed below. 1998, for the purpose of making a completely integrated system for selling its own genetic engineering seeds (such as herbicide-resistanct transgenic soybean) and its agricultural chemicals (herbicides, for instance). Monsanto thus is able to control a large part of the complete food chain of human beings using its genetically engineered seeds to gain enormous profits. The world's economy is becoming more integration and globalized. It is possible in the future few multinational corporations may decide our food consumption. Once toxic or allergic materials are found in the food chain engineered by them, it could be a catastrophe for the health of human beings.
Impacts on social and economic pattern
If bovine growth hormone (BGH) produced by genetic engineering are used in dairy, the milk yield of a dairy cow can increased by 30 percent and 10 per cent of its fodder saved at the same time. There will undoubtedly be major impacts on the dairy industry as a result (Liu and Xue, 1998b ).
In addition, many medicines, such as vaccines for treating malaria and cholera, will soon be delivered to patients in the form of new antigens synthesized within common fruits and vegetables bred by modern biotechnology. These foods will make the rates of illness and death in many countries (especially in the developing countries) fall precipitously, with the population growth rates increasing correspondingly. What will be the impacts on already inadequate economics and infrastructures of the concerned countries? Will it represent a benefit or a harm to our Earth burdened with huge populations (Miller,1998 )?
Impacts on biodiversity and sustainable agriculture
Foreign genes from other plants, animals and microbes are contained within many genetic engineering crops. These foreign genes can be transferred to other plants in the nature via the pollens of genetically transformed plants. This will pollute the pool of natural genetic resources. The damage to the environment and human society will be long-term, and the loss is incapable of being measured by money. Furthermore, because the majority of transgenic plants have desired traits such as high productivity, disease-pest resistance, stress resistance, farmers are attracted for economic interests, to grow these plants, rather than traditional crop varieties. Therefore, natural biological species might be ignored or even discarded. Consequently, the traditional crop varieties and natural biological species are likely to be lost and the genetic resource-base narrowed. Furthermore, some technology by encouraging the monoculture of crop varieties in certain areas may further add to loss of biodiversity.
In the long term, this erosion of the genetic base may undermine the resistance of plants to diseases and insect pests and this may result in reduced crop yields. Hence, global sustainable development could be put in jeopardy.
For another example, attracted by high financial returns over the last few years, an unprecedented numbers of farmers in one region of Andhra Pradesh state of India turned to plant a single hybrid cotton seed. Due to the combination of unfortunate weather patterns and a pest outbreaks in one year, the crops of these farmers failed.
Farmers, who had borrowed heavily to lease additional land and purchase pesticides, 
Impacts on socioeconomic welfare of countries and of communities
Application of genetic engineering technology to humans could make it possible, to diagnose and cure genetically-related diseases such as some cancers and haemophilia, 
Impacts on traditional culture
Some pious religious persons believe that because modern genetic technology changes, recodes and manipulates Nature that usurps the role of God.. internationally. These patents with such broad application not only could force smaller companies out of biotechnological business, but also might reduce the biotechnological research activities in certain countries and fields (Stone, 1995a) . The width of these patent rights granted has the capacity to create mega-monopolies
The patent system can also be used by some countries/individuals to usurp intellectual ownership of "native technologies". For instance, the neem tree, known as the "blessed tree", had been used by Indian farmers as a medicine for centuries. After conducting research on the tree's properties, however, a US company patented a method of extracting and stabilizing azadirachtin, a potent natural pesticide, from the neem tree. The patent could hurt Indian farmers because they could be forced to stop using the technology which they have been using for generations or pay royalties for its use (Wolfgang, 1995) . In general, developed countries possess a high level of biotechnological expertise, with greater ability to solve biosafety issues than developing countries. They are the exporters and beneficiaries of biotechnological products. Many developed countries involved in negotiations argued that the socioeconomic issues of biotechnologic change were too complex for them to contribute constructivity to the debate because of their relative ignorance, although the issues were important. They agreed there was an urgent need for socioeconomic issues to be studied exhaustively. It was agreed that it is appropriate for international biosafety legislation to take such issues into consideration, and the socioeconomic issues of biotechnology should be discussed alone in another global forum.
In contrast to developed countries, developing countries have low biotechnological capacities, with little ability to solve biosafety issues. They are the importers of biotechnology and potential victims of the adverse impacts of biotechnological products. As a result, some developing countries, such as India and China, believe that socioeconomic issues raised by modern biotechnology were very important to all countries, especially for the developing countries endowed with rich genetic biodiversity. They insisted that socioeconomic issues taken into account as an essential part of international biosafety legislation, that public safety should be protected through suitable policies and regulations. In addition, measures should be taken to ensure that economic activity and the distribution of income are economic opportunities and are not impaired by monopolization of biotechnologies, and it is needed to control production of genetic material such as seeds and associated chemical and biological substances by some private enterprises. They also requested that the Contracting Parties to The Convention on Biological Diversity who planned to produce with biotechnology a commodity that had been previously imported,
should notify in advance the other Parties whose exports would be reduced. The notification should be made sufficiently in advance (at least seven years), to enable the latter to make alternative production plans. When the affected Parties are developing countries, the Parties that replaced the imported products by biotechnological products should provide the affected Parties with financial and technical aid (Liu and Xue, 1998c ).
Thus it can be seen that, not only can biotechnology produce enormous social and economic benefits, but it may also result in many serious socioeconomic problems.
Those problems are intensified because of the vastly different stages of biotechnological development developed and less developed countries and regions and because of the varied economic and political situation of many countries and regions. Biotechnology policies need to accommodate those differences. Because of divergent development and social status of countries, it will be difficult to obtain global consensus in the short term on biotechnology policies and the socioeconomic issues which should be taken into account in such policies. It is possible that international disputation about biotechnology policies will continue for a long time.
Nevertheless if now biotechnology is to contribute the sustainable development of the world, international society must make concerted efforts via policy formulation to address the possible detrimental socioeconomic impacts of biotechnology, some of which have been highlighted in this contribution.
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